canrenone has been researched along with Heart Failure in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Claggett, B; de Denus, S; Desai, AS; Jutras, M; Lavoie, J; Leclair, G; Lewis, EF; O'Meara, E; Pfeffer, MA; Pitt, B; Rouleau, JL; Solomon, SD | 1 |
| Boccanelli, A; Clemenza, F; Conaldi, PG; Di Carlo, D; Di Lenarda, A; Gonzini, L; Latini, R; Lucci, D; Maggioni, AP; Masson, S; Mureddu, GF; Nicolis, EB; Vanasia, M | 1 |
| Bentivenga, C; Bestetti, A; Borghi, C; Caprio, M; Cicero, AFG; Cosentino, E; Derosa, G; Esposti, DD; Maffioli, P; Pitt, B; Scelsi, L; Spinardi, L; Vanasia, M | 1 |
| Atar, D; Clark, AL; Frankenstein, L; Fröhlich, H; Jensen, K; Katus, HA; Naci, H; Nee, P; Seide, S; Seiz, M; Täger, T; Uhlmann, L | 1 |
| Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
| D'Elia, E; Krum, H | 1 |
| Boccanelli, A; Cacciatore, G; Clemenza, F; de Simone, G; Di Lenarda, A; Gavazzi, A; Latini, R; Lucci, D; Maggioni, AP; Masson, S; Mureddu, GF; Porcu, M; Vanasia, M | 1 |
| Agostoni, P; Boccanelli, A | 1 |
| Bolorunduro, O; Chatterjee, S; Lichstein, E; Moeller, C; Moskovits, N; Mukherjee, D; Shah, N | 1 |
| Chen, YQ; Deng, SB; Du, JL; Hu, LJ; She, Q | 1 |
| Sanderson, JE | 1 |
| Casaburi, C; Cittadini, A; Di Gianni, A; Monti, MG; Saccà, L; Saldamarco, L; Scherillo, G; Serpico, R; Vanasia, M | 1 |
| Casaburi, C; Cittadini, A; Di Gianni, A; Isgaard, J; Monti, MG; Saccà, L; Saldamarco, L; Serpico, R; Strömer, H; Vanasia, M | 1 |
| Meloni, S; Nassiacos, D | 1 |
| Abdellah, AT; Clark, AL; Cleland, JG; Coletta, AP; Hobson, N; Witte, KK | 1 |
| Boccanelli, A; Cacciatore, G; Clemenza, F; De Maria, R; de Simone, G; Di Lenarda, A; Gavazzi, A; Gonzini, L; Latini, R; Maggioni, AP; Masson, S; Mureddu, GF; Porcu, M; Vanasia, M | 1 |
| Branch, R; Jackson, L; Levine, D; Ramsay, L | 1 |
3 review(s) available for canrenone and Heart Failure
| Article | Year |
|---|---|
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials.
Topics: Canrenone; Diuretics; Eplerenone; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Network Meta-Analysis; Randomized Controlled Trials as Topic; Spironolactone; Treatment Outcome | 2020 |
Eplerenone is not superior to older and less expensive aldosterone antagonists.
Topics: Canrenone; Cause of Death; Cost-Benefit Analysis; Drug Costs; Eplerenone; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Survival Rate; Treatment Outcome | 2012 |
Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.
Topics: Canrenone; Chronic Disease; Eplerenone; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Randomized Controlled Trials as Topic; Severity of Illness Index; Spironolactone; Ventricular Remodeling | 2013 |
4 trial(s) available for canrenone and Heart Failure
| Article | Year |
|---|---|
Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure.
Topics: Aged; Biomarkers; Blood Proteins; Canrenone; Female; Fibrosis; Galectin 3; Galectins; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Treatment Outcome | 2017 |
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Canrenone; Chronic Disease; Creatinine; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Treatment Outcome; Ultrasonography; Ventricular Remodeling; Young Adult | 2009 |
Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF.
Topics: Arrhythmias, Cardiac; Canrenone; Cardiac Pacing, Artificial; Defibrillators, Implantable; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Risk Assessment; Xanthines | 2007 |
Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
Topics: Aged; Aldosterone; Biomarkers; Canrenone; Disease Progression; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
10 other study(ies) available for canrenone and Heart Failure
| Article | Year |
|---|---|
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.
Topics: Canada; Canrenone; Clinical Trials as Topic; Heart Failure; Humans; Medication Adherence; Mineralocorticoid Receptor Antagonists; Russia; Spironolactone; United States | 2017 |
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Canrenone; Female; Glycated Hemoglobin; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists | 2019 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |
Mineralcorticoid antagonists in heart failure.
Topics: Aldosterone; Canrenone; Clinical Trials as Topic; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists | 2014 |
[The EMPHASIS-HF study].
Topics: Aldosterone; Biomarkers; Canrenone; Cause of Death; Double-Blind Method; Early Termination of Clinical Trials; Eplerenone; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Male; Mineralocorticoid Receptor Antagonists; Models, Cardiovascular; Molecular Structure; Multicenter Studies as Topic; Myocardial Infarction; Patient Selection; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Research Design; Risk; Spironolactone | 2011 |
New treatments for myocardial fibrosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Clinical Trials as Topic; Endomyocardial Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Rats; Spironolactone | 2002 |
Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
Topics: Administration, Oral; Aldosterone; Animals; Canrenone; Collagen; Cyclodextrins; Disease Models, Animal; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; gamma-Cyclodextrins; Heart Failure; Hemodynamics; Hydroxyproline; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2002 |
Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
Topics: Animals; Calcium-Transporting ATPases; Canrenone; Drug Therapy, Combination; Heart Failure; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Norepinephrine; Ramipril; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Left; Ventricular Remodeling | 2003 |
[Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Canrenone; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies | 2005 |
Elimination of canrenone in congestive heart failure and chronic liver disease.
Topics: Aged; Canrenone; Chronic Disease; Creatinine; Female; Half-Life; Heart Failure; Humans; Liver Diseases; Male; Middle Aged; Pregnadienes; Serum Albumin; Spironolactone | 1977 |